![Dosing of mesna to avoid urothelial toxicity from cyclophosphamide infusion - Journal of Prescribing Practice Dosing of mesna to avoid urothelial toxicity from cyclophosphamide infusion - Journal of Prescribing Practice](https://www.prescribingpractice.com/media/bp5fx5du/calculation_16_1000x667.jpg)
Dosing of mesna to avoid urothelial toxicity from cyclophosphamide infusion - Journal of Prescribing Practice
![Substitution of Oral for Intravenous Cyclophosphamide in Membranous Nephropathy | American Society of Nephrology Substitution of Oral for Intravenous Cyclophosphamide in Membranous Nephropathy | American Society of Nephrology](https://kidney360.asnjournals.org/content/kidney360/1/9/943/F1.large.jpg)
Substitution of Oral for Intravenous Cyclophosphamide in Membranous Nephropathy | American Society of Nephrology
![Journal of Prescribing Practice - Dosing of mesna to avoid urothelial toxicity from cyclophosphamide infusion Journal of Prescribing Practice - Dosing of mesna to avoid urothelial toxicity from cyclophosphamide infusion](https://www.prescribingpractice.com/media/qi5p2ayx/jprp-2022-4-8-342_f01.jpg)
Journal of Prescribing Practice - Dosing of mesna to avoid urothelial toxicity from cyclophosphamide infusion
![Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor–Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00 | Journal of Clinical Oncology Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor–Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00 | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2016/jco.2015.64.34.issue-28/jco.2015.65.6595/20161107/images/medium/jco656595t2.gif)
Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor–Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00 | Journal of Clinical Oncology
Draft Guidance on Cyclophosphamide Active Ingredient: Cyclophosphamide Dosage Form; Route: Tablet; oral Recommended Studies: Two
![High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy | British Journal of Cancer High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6603097/MediaObjects/41416_2006_Article_BF6603097_Fig1_HTML.gif)
High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy | British Journal of Cancer
![Cyclophosphamide pulse therapy as treatment for severe interstitial lung diseases. - Abstract - Europe PMC Cyclophosphamide pulse therapy as treatment for severe interstitial lung diseases. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7247101/bin/SVDLD-36-157-g005.jpg)
Cyclophosphamide pulse therapy as treatment for severe interstitial lung diseases. - Abstract - Europe PMC
![Effect of Cyclophosphamide and Glucocorticoid Therapy in IgA Nephropathy: A Single-Center Retrospective Analysis | American Society of Nephrology Effect of Cyclophosphamide and Glucocorticoid Therapy in IgA Nephropathy: A Single-Center Retrospective Analysis | American Society of Nephrology](https://kidney360.asnjournals.org/content/kidney360/3/3/506/F1.large.jpg)
Effect of Cyclophosphamide and Glucocorticoid Therapy in IgA Nephropathy: A Single-Center Retrospective Analysis | American Society of Nephrology
![Cyclophosphamide induced physiological and biochemical changes in mice with an emphasis on sensitivity analysis - ScienceDirect Cyclophosphamide induced physiological and biochemical changes in mice with an emphasis on sensitivity analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0147651320317255-ga1.jpg)
Cyclophosphamide induced physiological and biochemical changes in mice with an emphasis on sensitivity analysis - ScienceDirect
![Metronomic oral cyclophosphamide in relapsed ovarian cancer | International Journal of Gynecologic Cancer Metronomic oral cyclophosphamide in relapsed ovarian cancer | International Journal of Gynecologic Cancer](https://ijgc.bmj.com/content/ijgc/31/7/1037/F1.large.jpg)
Metronomic oral cyclophosphamide in relapsed ovarian cancer | International Journal of Gynecologic Cancer
![Frontiers | High-Dose Cyclophosphamide Administration Orchestrates Phenotypic and Functional Alterations of Immature Dendritic Cells and Regulates Th Cell Polarization Frontiers | High-Dose Cyclophosphamide Administration Orchestrates Phenotypic and Functional Alterations of Immature Dendritic Cells and Regulates Th Cell Polarization](https://www.frontiersin.org/files/Articles/548602/fphar-11-00775-HTML/image_m/fphar-11-00775-g001.jpg)
Frontiers | High-Dose Cyclophosphamide Administration Orchestrates Phenotypic and Functional Alterations of Immature Dendritic Cells and Regulates Th Cell Polarization
![Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer | npj Breast Cancer Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-020-0171-1/MediaObjects/41523_2020_171_Fig1_HTML.png)